153 related articles for article (PubMed ID: 25012485)
1. CIP2A and PP2A in human leptomeninges, arachnoid granulations and meningiomas.
Johnson MD; Reeder JE; O'Connell M; Woodford M; Walter K
J Clin Neurosci; 2014 Dec; 21(12):2228-32. PubMed ID: 25012485
[TBL] [Abstract][Full Text] [Related]
2. MKP-3 regulates PDGF-BB effects and MAPK activation in meningioma cells.
Johnson MD; Reeder JE; O'Connell M
J Clin Neurosci; 2015 Apr; 22(4):752-7. PubMed ID: 25698542
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis.
Johnson MD; O'Connell MJ; Walter K
BMC Complement Altern Med; 2013 Nov; 13():303. PubMed ID: 24188277
[TBL] [Abstract][Full Text] [Related]
4. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura.
Johnson MD; O'Connell M
Hum Pathol; 2013 Jun; 44(6):1118-24. PubMed ID: 23317544
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3.
Johnson MD; O'Connell M; Facik M; Maurer P; Jahromi B; Pilcher W
J Neurooncol; 2012 Mar; 107(1):121-31. PubMed ID: 21971737
[TBL] [Abstract][Full Text] [Related]
6. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.
Johnson MD; O'Connell M; Pilcher W
J Neurooncol; 2011 Feb; 101(3):441-8. PubMed ID: 20596751
[TBL] [Abstract][Full Text] [Related]
7. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3B expression in human leptomeninges and meningiomas.
Johnson MD; Reeder JE; O'Connell M
Oncol Lett; 2016 Dec; 12(6):5344-5348. PubMed ID: 28101245
[TBL] [Abstract][Full Text] [Related]
9. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
10. p38MAPK activation and DUSP10 expression in meningiomas.
Johnson MD; Reeder JE; O'Connell M
J Clin Neurosci; 2016 Aug; 30():110-114. PubMed ID: 27050915
[TBL] [Abstract][Full Text] [Related]
11. Mesothelin expression in the leptomeninges and meningiomas.
Johnson MD; Vito F; O'Connell MJ
J Histochem Cytochem; 2008 Jun; 56(6):579-85. PubMed ID: 18347077
[TBL] [Abstract][Full Text] [Related]
12. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway.
Johnson MD; O'Connell MJ; Vito F; Pilcher W
J Neuropathol Exp Neurol; 2009 Nov; 68(11):1177-83. PubMed ID: 19816200
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
15. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
[TBL] [Abstract][Full Text] [Related]
16. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis.
Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G
Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585
[TBL] [Abstract][Full Text] [Related]
17. Chronic Cigarette Smoke Exposure Subdues PP2A Activity by Enhancing Expression of the Oncogene CIP2A.
Nath S; Ohlmeyer M; Salathe MA; Poon J; Baumlin N; Foronjy RF; Geraghty P
Am J Respir Cell Mol Biol; 2018 Dec; 59(6):695-705. PubMed ID: 30011381
[TBL] [Abstract][Full Text] [Related]
18. CIP2A inhibits PP2A in human malignancies.
Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
[TBL] [Abstract][Full Text] [Related]
19. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
[TBL] [Abstract][Full Text] [Related]
20. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.
Wang J; Okkeri J; Pavic K; Wang Z; Kauko O; Halonen T; Sarek G; Ojala PM; Rao Z; Xu W; Westermarck J
EMBO Rep; 2017 Mar; 18(3):437-450. PubMed ID: 28174209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
